Gonorrhea Screening Without Symptoms in Kathmandu — Catch Silent Infections Early Asymptomatic Screening at All Exposure Sites

Overview — Why Gonorrhea Screening Matters Even Without Symptoms

Gonorrhea, caused by the bacterium Neisseria gonorrhoeae, is one of the most common sexually transmitted infections worldwide. What makes it particularly dangerous is that most infections are asymptomatic — studies suggest that up to 50% of infections in women and 10% in men produce no noticeable symptoms. These silent infections can persist for weeks or months, causing damage and transmitting to partners without anyone knowing.

The reason asymptomatic screening is essential is that gonorrhea does not remain harmless just because you feel fine. Untreated gonorrhea can ascend from the cervix to the uterus and fallopian tubes causing pelvic inflammatory disease, infertility and ectopic pregnancy in women. In men, it can cause epididymitis and urethral strictures. It also increases susceptibility to HIV transmission and can cause disseminated gonococcal infection — a rare but serious complication affecting joints, skin and heart.

Perhaps most importantly, asymptomatic gonorrhea is how the infection spreads through communities. People who feel perfectly healthy transmit the bacteria to partners who may develop symptoms or complications. The only way to break this cycle is through routine screening of sexually active individuals, particularly those with risk factors such as multiple partners, inconsistent condom use, or partners of unknown status.

At Thamel Clinic, we provide asymptomatic gonorrhea screening using nucleic acid amplification testing (NAAT) at all relevant anatomical sites. This page explains who should be screened, what tests are used, how to prepare, and what happens if your test is positive.

Why Screen Without Symptoms?

The fundamental reason for asymptomatic screening is that gonorrhea frequently causes no symptoms, yet it is not harmless. In women, untreated gonorrhea can ascend to the uterus and fallopian tubes causing pelvic inflammatory disease (PID), which leads to chronic pelvic pain, tubal infertility and ectopic pregnancy. In men, it can cause epididymitis, urethral strictures and rarely, infertility.

Asymptomatic infection is also the primary driver of transmission. People who feel perfectly healthy carry and transmit the bacteria to partners. A person can be infected for weeks or months without knowing, during which time they may have multiple sexual partners. Screening is the only way to identify these silent carriers and break transmission chains.

Additionally, gonorrhea increases susceptibility to HIV. The inflammation caused by gonococcal infection draws immune cells to the genital area, creating portals for HIV entry. Treating gonorrhea reduces this risk. Co-infection with HIV is also common, which is why HIV testing should always accompany gonorrhea screening.

• Most gonorrhea infections are asymptomatic, especially in women.
• Untreated infection causes PID, infertility and ectopic pregnancy.
• Asymptomatic carriers transmit the bacteria unknowingly.
• Gonorrhea increases HIV transmission risk.
• Screening is the only way to detect silent infection.
• Early treatment prevents all major complications.

Who Should Be Screened and How Often

Screening recommendations depend on risk level and anatomical exposure. Sexually active adults with multiple partners, inconsistent condom use, or partners of unknown status should be screened at least annually. Men who have sex with men (MSM) should be screened every 3–6 months at all sites of exposure — urethra, rectum and pharynx — because extragenital infection is common and often asymptomatic.

Women under 25 should be screened annually regardless of reported risk because they have the highest rates of gonorrhea and the most severe complications. Pregnant women should be screened at their first antenatal visit because gonorrhea in pregnancy can cause preterm delivery, low birth weight and neonatal eye infection.

Anyone with a new partner, after unprotected sex, or with symptoms such as discharge, burning urination, pelvic pain, sore throat or rectal discomfort should be tested promptly. Even if you feel fine, a recent high-risk exposure warrants testing after the appropriate window period — typically 1–2 weeks for gonorrhea NAAT.

• Annual screening for sexually active adults with risk factors.
• Every 3–6 months for MSM at all exposure sites.
• Annual screening for all sexually active women under 25.
• Screening at first antenatal visit for pregnant women.
• After new partners or unprotected sex with unknown-status partners.
• Anyone with discharge, burning, pelvic pain or sore throat.

Testing at All Exposure Sites

The most common mistake in gonorrhea screening is testing only one site when infection may be present at multiple sites. Gonorrhea can infect the urethra (causing discharge and burning in men), cervix (often asymptomatic in women), rectum (causing discharge, pain or bleeding), and throat (causing sore throat or no symptoms). Each site requires its own specimen.

Nucleic acid amplification testing (NAAT) is the gold standard for gonorrhea diagnosis. It detects bacterial DNA with high sensitivity and specificity. For urethral infection, a urine sample or urethral swab is used. For cervical infection, a vaginal or cervical swab is preferred. For rectal and pharyngeal infection, swabs from those sites are required.

Urine-only testing misses extragenital infection. A man who has sex with men may have negative urine but positive rectal or pharyngeal gonorrhea. Similarly, a woman with cervical infection may have negative urine. This is why site-specific testing based on sexual practices is essential for accurate diagnosis.

• Gonorrhea can infect urethra, cervix, rectum and throat.
• Each site requires its own specimen for accurate testing.
• NAAT is the gold standard for gonorrhea diagnosis.
• Urine testing misses rectal and pharyngeal infection.
• Site-specific testing is essential for MSM and women.
• Window period is ~1–2 weeks after exposure.

What to Expect During Screening

Gonorrhea screening is quick, simple and mostly painless. For urine testing, you will provide a urine sample — first catch urine is preferred because it contains the highest concentration of bacteria. For swab testing, a clinician will collect samples from the relevant sites using a small swab. The process takes only a few minutes.

You do not need to fast or prepare specially for gonorrhea testing. However, you should avoid urinating for at least 1 hour before providing a urine sample to ensure adequate bacterial concentration. If you are being tested for multiple STIs, blood tests for HIV, syphilis and hepatitis may also be performed at the same visit.

Results are typically available within 1–2 days. If your test is positive, your clinician will explain the results, prescribe appropriate treatment, discuss partner notification, and arrange follow-up testing. If negative but you had a recent high-risk exposure, repeat testing after the window period may be recommended.

• Urine sample or swab — quick and mostly painless.
• No fasting required; avoid urinating for 1 hour before urine test.
• Blood tests for HIV, syphilis and hepatitis may be done at same visit.
• Results typically available within 1–2 days.
• Positive results followed by treatment and partner management.
• Negative results may need repeat testing if exposure was recent.

If Your Test Is Positive

Gonorrhea is curable with antibiotics, but treatment is becoming more complicated due to antimicrobial resistance. The current recommended treatment is ceftriaxone 500 mg as a single intramuscular injection, often combined with azithromycin or doxycycline to cover possible chlamydia co-infection. Oral alternatives are less effective due to resistance.

It is critical that you complete the full treatment and abstain from sexual contact until 7 days after treatment is complete and partners are treated. Gonorrhea can be transmitted even during treatment, and incomplete treatment or reinfection from untreated partners leads to persistent infection.

All partners from the past 60 days should be tested and treated, even if they have no symptoms. Partner notification can be done by you or with clinic assistance. Retesting at 3 months is recommended to detect reinfection, which is common when partners are not treated.

• Ceftriaxone 500 mg IM injection is current first-line treatment.
• Azithromycin or doxycycline often added to cover chlamydia co-infection.
• Abstain from sex for 7 days after treatment and until partners treated.
• All partners from past 60 days need testing and treatment.
• Retest at 3 months to detect reinfection.
• Antimicrobial resistance makes correct treatment critical.

Cost and Access in Kathmandu

Gonorrhea NAAT testing at Thamel Clinic costs Rs. 2,000–4,000 per site, depending on whether urine or swab testing is needed and how many sites are tested. Testing multiple sites (e.g., urine plus rectal plus pharyngeal) may cost more but provides comprehensive screening. Ceftriaxone treatment costs approximately Rs. 500–1,000.

Many patients assume STI testing is expensive, but gonorrhea screening is comparable to routine blood tests. Package pricing is available for patients who need multiple STI tests or multiple sites. The cost of missing a gonorrhea infection — PID, infertility, HIV risk — far exceeds the cost of testing.

For patients concerned about cost, free gonorrhea testing is available through government health posts and some NGO programmes in Kathmandu. However, these programmes may not offer site-specific testing for extragenital infection or the same level of partner management and follow-up that a specialized clinic provides.

• NAAT testing costs Rs. 2,000–4,000 per site.
• Ceftriaxone treatment costs Rs. 500–1,000.
• Package pricing available for multiple tests or sites.
• Total screening and treatment typically under Rs. 6,000.
• Free testing available through government and NGO programmes.
• Transparent itemized pricing before any test or treatment.

Gonorrhea Screening Services — Indicative Costs

Prices are in Nepali Rupees and are indicative; confirm current rates when booking.

Related Services & Guides